4Jordan SC, Buckingham B ,Sakai R, et al. Studies of immune-complex glomemlonephritis mediated by thyroglobulin. N Engl J Med, 1981, 304(20) :1212 - 1215.
5Sato Y,Sasaki M ,Kan R,et al. Thyoid antigen-mediated glomerulonephritis in Graves'disease. Clin Nephrol, 1989,31 ( 1 ) :49 - 52.
7Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil is assoeiated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid, 2000, 10(7) :595 - 599.
8Noh JY, Asari T, Hamada N, et al. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol,2001,54(5 ) :651 -654.
9Lee E, Hirouchi M, Hosokawa M, et al. Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heine structure. Biochem Pharmacol, 1988,37( 11 ) :2151 -2153.
10Yu F, Zhao MH, Zhang YK,et al. Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (FIU) induced ANCA Positive Vasculitis are associated with disease activity. Clin Exp Immunol, 2005,139(3) :569 -574.
8Silva FG. Acute postinfectious glomerulonephritis and glomerulonephritis complicating persistent bacterial infection. In : Jennette JC, Olson JL, Schwartz MM, et al. ed. Heptinstall's Pathology of the kidney. 4^th ed. Philadelphia: Lippincott-Raven, 1998 : 174 - 178,389 - 453.
9Cu G, Mezzano S, Bannan JD, et al. Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute poststreptococcal glomerulonephritis. Kidney Int, 1998,54 : 819 - 826.
10Ralf Dikow, Eberhard Ritz. The patient with diabetes mellitus. In: Davison AM, Cameron JS, Grunfeld JP, et al ed. Oxford Textbook of Clinical Nephrology. 3^rd edition. Vol 2. New York: Oxford University Press Inc, 2005:659 -678.
